Acadian Asset Management LLC Taro Pharmaceutical Industries LTD Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$35.46 - $40.13 $8.81 Million - $9.97 Million	-248,423 Reduced 99.75%	630 $23,000
Q2 2023 Aug 07, 2023	SELL	$24.24 - $40.97 $260,361 - $440,058	-10,741 Reduced 4.13%	249,053 $9.41 Million
Q1 2023 May 11, 2023	SELL	$23.0 - $31.59 $225,561 - $309,803	-9,807 Reduced 3.64%	259,794 $6.29 Million
Q4 2022 Feb 14, 2023	SELL	$27.6 - $32.99 $45,898 - $54,862	-1,663 Reduced 0.61%	269,601 $7.8 Million
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $980,924 - $1.36 Million	-34,131 Reduced 11.18%	271,264 $8.09 Million
Q2 2022 Aug 09, 2022	SELL	$35.0 - $43.59 $736,120 - $916,784	-21,032 Reduced 6.44%	305,395 $11 Million
Q1 2022 May 12, 2022	SELL	$43.12 - $50.3 $600,834 - $700,880	-13,934 Reduced 4.09%	326,427 $14.1 Million
Q4 2021 Feb 10, 2022	SELL	$47.6 - $65.0 $174,311 - $238,030	-3,662 Reduced 1.06%	340,361 $17 Million
Q3 2021 Nov 12, 2021	SELL	$62.34 - $73.38 $209,088 - $246,116	-3,354 Reduced 0.97%	344,023 $21.9 Million
Q2 2021 Aug 11, 2021	SELL	$70.26 - $76.64 $261,015 - $284,717	-3,715 Reduced 1.06%	347,377 $25 Million
Q1 2021 May 11, 2021	SELL	$70.48 - $79.95 $1.23 Million - $1.39 Million	-17,430 Reduced 4.73%	351,092 $25.9 Million
Q4 2020 Feb 11, 2021	SELL	$54.4 - $73.42 $283,804 - $383,032	-5,217 Reduced 1.4%	368,522 $27.1 Million
Q3 2020 Nov 09, 2020	SELL	$54.41 - $68.2 $203,330 - $254,863	-3,737 Reduced 0.99%	373,739 $20.5 Million
Q2 2020 Aug 12, 2020	BUY	$61.66 - $70.16 $1.51 Million - $1.71 Million	24,436 Added 6.92%	377,476 $25.1 Million
Q1 2020 May 11, 2020	BUY	$59.35 - $88.73 $1.52 Million - $2.27 Million	25,547 Added 7.8%	353,040 $21.6 Million
Q4 2019 Feb 06, 2020	SELL	$74.18 - $97.92 $219,201 - $289,353	-2,955 Reduced 0.89%	327,493 $28.8 Million
Q3 2019 Nov 07, 2019	SELL	$75.36 - $86.57 $252,079 - $289,576	-3,345 Reduced 1.0%	330,448 $24.9 Million
Q2 2019 Aug 08, 2019	SELL	$83.92 - $108.88 $2.23 Million - $2.9 Million	-26,621 Reduced 7.39%	333,793 $28.5 Million
Q1 2019 May 09, 2019	BUY	$85.97 - $108.09 $4.46 Million - $5.6 Million	51,826 Added 16.79%	360,414 $39 Million
Q4 2018 Feb 07, 2019	BUY	$78.25 - $107.92 $2.13 Million - $2.93 Million	27,175 Added 9.66%	308,588 $26.1 Million
Q3 2018 Oct 30, 2018	BUY	$97.82 - $116.09 $4.45 Million - $5.28 Million	45,483 Added 19.28%	281,413 $27.7 Million
Q2 2018 Jul 24, 2018	BUY	$97.62 - $120.59 $13.3 Million - $16.4 Million	136,287 Added 136.78%	235,930 $27.3 Million
Q1 2018 Apr 12, 2018	SELL	$95.91 - $107.26 $922,078 - $1.03 Million	-9,614 Reduced 8.8%	99,643 $9.84 Million
Q4 2017 Jan 18, 2018	BUY	$104.5 - $126.38 $6.93 Million - $8.38 Million	66,306 Added 154.38%	109,257 $11.4 Million
Q3 2017 Oct 13, 2017	BUY	$97.26 - $116.2 $4.18 Million - $4.99 Million	42,951	42,951 $4.84 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account